75 related articles for article (PubMed ID: 2351945)
1. Argument for esophageal cancer screening in high risk U.S. populations.
Lucas CC
J Fla Med Assoc; 1990 May; 77(5):526-9. PubMed ID: 2351945
[TBL] [Abstract][Full Text] [Related]
2. [Screening for upper G-I tract cancer by gastroscopy in a 2,000 suspected population].
Wang GQ
Zhonghua Zhong Liu Za Zhi; 1989 May; 11(3):201-3. PubMed ID: 2612334
[TBL] [Abstract][Full Text] [Related]
3. Early detection of oesophageal carcinoma in southern Thailand.
Chanvitan A; Geater AF; Ubolcholket S; Huang GJ
J Med Assoc Thai; 1990 Oct; 73(10):565-71. PubMed ID: 2280204
[TBL] [Abstract][Full Text] [Related]
4. [Hemoccult test bead for screening of upper G-I tract cancer].
Qin DX
Zhonghua Zhong Liu Za Zhi; 1989 Jul; 11(4):307-9. PubMed ID: 2625115
[TBL] [Abstract][Full Text] [Related]
5. Double blind randomized trial on occult blood bead (OBB) and gastroscopy-pathology screening for gastro-oesophageal cancer.
Qin DX; Wang GQ; Wang ZY
Eur J Cancer Prev; 1997 Apr; 6(2):158-61. PubMed ID: 9237065
[TBL] [Abstract][Full Text] [Related]
6. [Feature of screening-detected cancer and progress of treatment--esophageal cancer].
Kouzu T; Suzuki Y; Yoshimura S; Yoshimura N; Hishikawa E; Arima M
Gan To Kagaku Ryoho; 1998 Aug; 25(10):1499-504. PubMed ID: 9725040
[TBL] [Abstract][Full Text] [Related]
7. Inspection for gastric occult blood at regular intervals is the optimum program for the screening of esophageal-gastric cancer.
Qin D; Wang G; Zhang X; Zuo J; Yuan F; Li M; Geng C; Wang L; Jv C; Chen J
Ann Ital Chir; 1995; 66(1):41-4; discussion 45-6. PubMed ID: 7668481
[TBL] [Abstract][Full Text] [Related]
8. Cytological screening and 15 years' follow-up (1986-2001) for early esophageal squamous cell carcinoma and precancerous lesions in a high-risk population in Anyang County, Henan Province, Northern China.
Wang LD; Yang HH; Fan ZM; Lü XD; Wang JK; Liu XL; Sun Z; Jiang YN; He X; Zhou Q
Cancer Detect Prev; 2005; 29(4):317-22. PubMed ID: 16118042
[TBL] [Abstract][Full Text] [Related]
9. Endoscopic surveillance of Barrett's esophagus: another viewpoint.
Richter JE
Am J Gastroenterol; 1993 May; 88(5):630-2. PubMed ID: 8480722
[No Abstract] [Full Text] [Related]
10. Effectiveness and economic impact of screening for colorectal cancer by mass fecal occult blood testing.
Helm JF; Russo MW; Biddle AK; Simpson KN; Ransohoff DF; Sandler RS
Am J Gastroenterol; 2000 Nov; 95(11):3250-8. PubMed ID: 11095350
[TBL] [Abstract][Full Text] [Related]
11. Long-term results of operation for 420 patients with early squamous cell esophageal carcinoma discovered by screening.
Wang GQ; Jiao GG; Chang FB; Fang WH; Song JX; Lu N; Lin DM; Xie YQ; Yang L
Ann Thorac Surg; 2004 May; 77(5):1740-4. PubMed ID: 15111177
[TBL] [Abstract][Full Text] [Related]
12. Screening for Barrett's esophagus by balloon cytology.
Fennerty MB; DiTomasso J; Morales TG; Peterson D; Karmakar A; Fernandez T; Sampliner R
Am J Gastroenterol; 1995 Aug; 90(8):1230-2. PubMed ID: 7639220
[TBL] [Abstract][Full Text] [Related]
13. Prevention and screening for breast cancer.
Harper GR; Englisbe BH
Cancer Detect Prev; 1993; 17(4-5):551-5. PubMed ID: 8242657
[TBL] [Abstract][Full Text] [Related]
14. Late-stage breast cancer among women with recent negative screening mammography: do clinical encounters offer opportunity for earlier detection?
Mouchawar J; Taplin S; Ichikawa L; Barlow WE; Geiger AM; Weinmann S; Gilbert J; Manos MM; Ulcickas Yood M
J Natl Cancer Inst Monogr; 2005; (35):39-46. PubMed ID: 16287884
[TBL] [Abstract][Full Text] [Related]
15. The place of fecal occult blood test in colorectal cancer screening in 2006: the U.S. perspective.
Bond JH
Am J Gastroenterol; 2006 Feb; 101(2):219-21. PubMed ID: 16454821
[No Abstract] [Full Text] [Related]
16. Cancer screening among the overweight and obese in Canada.
Mitchell RS; Padwal RS; Chuck AW; Klarenbach SW
Am J Prev Med; 2008 Aug; 35(2):127-32. PubMed ID: 18617081
[TBL] [Abstract][Full Text] [Related]
17. Colorectal cancer: risk factors and recommendations for early detection.
Read TE; Kodner IJ
Am Fam Physician; 1999 Jun; 59(11):3083-92. PubMed ID: 10392591
[TBL] [Abstract][Full Text] [Related]
18. Cost-benefit analysis of capsule endoscopy compared with standard upper endoscopy for the detection of Barrett's esophagus.
Gerson L; Lin OS
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):319-25. PubMed ID: 17368231
[TBL] [Abstract][Full Text] [Related]
19. Colorectal cancer screening with faecal occult blood test within a multiple disease screening programme: an experience from Keelung, Taiwan.
Yang KC; Liao CS; Chiu YH; Yen AM; Chen TH
J Med Screen; 2006; 13 Suppl 1():S8-13. PubMed ID: 17227635
[TBL] [Abstract][Full Text] [Related]
20. Screening for colorectal cancer--United States, 1992-1993, and new guidelines.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 1996 Feb; 45(5):107-10. PubMed ID: 8592492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
